Segments - Aortic Stents Market by Product (Thoracic Aortic Stent Graft and Abdominal Aortic Stent Graft), Design (Self-expanding Stents, Balloon-expandable Stents, Covered Stents, and Bare-metal stents), End-Use (Hospitals and Ambulatory Surgical Centers), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
The global aortic stents market size was valued at USD 3.45 Bn in 2022 and is likely to reach USD 6.41 Bn by 2031, expanding at a CAGR of 5.8% during 2023–2031. Rising incidences of aortic diseases and disorders among the population are anticipated to augment the market.
The aortic stent is a thin metal mesh structure, covered, and supported by a leak-proof polyester fabric, used to treat aortic diseases, also called a graft. They are implanted in the abnormally bulged part of the aorta, to widen the aortic passage. This prevents any further obstruction to the blood flow. Aortic diseases and disorders such as aortic aneurysms, aortic dissection, and others are treated using this minimally invasive treatment method.
Aorta is the largest artery in the human body, which has a huge network of smaller arteries, veins, and capillaries. Aorta is responsible to conduct the purified blood from the heart to the circulatory system. Aortic diseases are caused by the weakening of the aorta, congenital heart diseases, atherosclerosis, high blood pressure, and high blood cholesterol levels. People who have a history of smoking, are prone to developing an aortic aneurysm.
The aorta develops a bulge in the thoracic or abdominal region. The abnormalities are caused in the area aortic opening inside the heart, the aortic valves, or the lower aortic region. The aortic ballooning or unusual bulging caused in the region leads to the dissection or the rupture of the aorta in the region. This causes sudden intense pain, difficulty in breathing, loss of consciousness, and other symptoms. Highly weakened aortic walls are generally caused by untreated hypertension or a sudden injury.
The treatment of aortic aneurysm depends on the location, chronicity, and the patient’s physical condition. An aortic stent implant or endovascular grafting helps strengthen the aortic walls to hold the appropriate posture in order to prevent any dissection. Depending upon the size of the aneurysm, the stent is implanted in the patient’s aorta, with the help of catheters. The grafts form an inner support structure to prevent aortic collapse.
The aortic stents are manufactured out of several different materials. The inside metal mesh is generally manufactured of stainless steel, nitinol, and cobalt-chromium. The outer polyester coating is made of high-quality leak-proof polymer. The stent comes in different designs which vary in terms of the way of execution while implanting. For instance, the balloon-expandable stents.
The COVID-19 pandemic positively impacted the market growth, from the initial pandemic period owing to the high chances of the COVID-affected patients developing abdominal aortic aneurysms (AAA). The Coronavirus affected the heart directly by causing the inflammation of the cardiac muscles called myocarditis.
Moreover, the patients suffered from the severe impact of the infection on the disruption and chronic weakening of the aortic wall which led to the aortic rupture, dissection, and the AAA. This helped the market grow during the pandemic and the post-pandemic period.
The increasing prevalence of aortic diseases drives the market. Aortic diseases are caused due to multiple factors such as age, blood pressure, and congenital (by birth) heart defects. Prolonged untreated health conditions such as hypertension, high cholesterol, and high blood glucose levels cause the weakening of the aortic walls and other vascular walls. The weakened part of the aorta becomes more prone to internal rupture, aortic dissections aortic aneurysm, and aortic stenosis. Furthermore, the increasing prevalence of the disease among the elderly population is expected to drive the market.
Rising demand for minimally invasive surgical procedures fuels the market growth. The minimally invasive procedures, cause less damage to the surrounding tissue area of operation. Traditionally vascular surgeries required longer recovery times and stay at the hospitals. The minimum invasive surgeries ensure reduced surgery time, reduced risk while the operation, and reduced time for the patient’s recovery. The enhanced advantages of the non-invasive treatment drive the market.
The risks of post-operation complications of the surgery restrain the market. The aortic grafting procedure is subject to post-operation complications such as the dislocation of the stent, improper functioning of the stent, or the narrowing of the aortic vessel and internal bleeding around the stent which requires another surgery in order to widen the previous stent, which hampers the market growth.
Increasing demand for cost-effective, minimally invasive, and safety-ensured aortic stents is expected to create lucrative opportunities for market growth. Moreover, the technological advancements to develop self-functioning stents are a major market opportunity, leaving immense scope for research and development technology.
The market report includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Aortic Stents Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Product (Thoracic Aortic Stent Graft, and Abdominal Aortic Stent Graft), Design (Self-expanding Stents, Balloon-expandable Stents, Covered Stents, and Bare-metal stents), and End-User (Hospitals, and Ambulatory Surgical Centers) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
Key Players Covered in the Report |
Cook Group companies; Medtronic; W. L. Gore & Associates, Inc.; Lombard Medical; Artivion, Inc.; Terumo Medical Corporation; BD; and Endologix LLC. |
Based on product, the aortic stents market is divided into thoracic aortic stent graft and abdominal aortic stent graft. The thoracic aortic stent segment held a major market share in the base year, owing to the increasing prevalence of the disease among the geriatric population.
According to the Centers for Disease Control and Prevention (CDC), thoracic aneurysm becomes more prevalent in accordance with increasing age. Moreover, the rising number of people with untreated Arterial hypertension (HTN) is another leading cause of thoracic aortic aneurysm, due to the chronic weakening of the internal vascular walls.
For instance, on August 25, 2021, the World Health Organization there are about more than 700 million people in the world with untreated hypertension.
The abdominal aortic stent segment is expected to expand at a significant growth rate during the projection period due to rising cases of atherosclerosis among people. The disease causes the narrowing of the internal arterial walls with a sticky substance called plaque. Moreover, high blood pressure leads to atherosclerosis which further increases the risks of aortic aneurysm, which in turn drives the segment.
On the basis of design, the market is segregated into self-expanding stents, balloon-expandable stents, covered stents, and bare-metal stents. The balloon-expandable stents segment held a key share in 2022, owing to the rising demand for non-invasive intra-vascular surgeries. The catheter with the balloon at the tip is placed through the aorta which reaches the point of operation. The balloon expands the plaque formed and creates room for the stent.
Post ballooning the stent is then inserted and expanded to support the aortic walls. The implanted stent remains in the aorta to prevent any obstruction to normal blood flow due to the plaque. The minimally invasive nature of the surgery fuels the segment’s growth.
The self-expanding stents segment is projected to register a considerable CAGR during the forecast period due to the ease of deployment for doctors. The self-expanding stents, as the name suggests, expand on insertion and push the plaque aside. The catheter that delivers the stent placed the stent in the right place, and retrieves post the stent expands. The operational ease and operational efficiency are expected to boost the segment growth in the coming years.
On the basis of end-user, the aortic stents market is segmented into hospitals and ambulatory surgical centers. The hospitals segment held a key market share in 2022, owing to the advanced medical facilities available in the hospitals. Hospitals are complex healthcare ecosystems that are powered by advanced diagnostic tools, experienced doctors, surgeons, and staff. Automated patient care systems and other healthcare assistance facilities enhance the patient experience and trust in the healthcare provider. The holistic approach of hospital facilities toward patient care boosts the segment growth.
The Ambulatory surgical centers (ASC) are expected to register a robust growth rate during the forecast period owing to the customizability that it offers to physicians. The physicians get to customize the ASC according to the requirement of their specialty. The ASCs play a prominent role for big hospitals, that provide outpatient surgical facilities via ASCs. Furthermore, the patients get cost-effective solutions from ambulatory surgical centers, which is expected to drive the segment.
In terms of region, the global aortic stents market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America dominated the market during 2022, owing to the increasing prevalence of cardiovascular diseases in the region.
For instance, according to the CDC, cardiovascular diseases are the leading cause of death among the natives of the U.S. In 2021, 695,000 people died due to heart disease in the United States.
The advanced healthcare infrastructure in the region is positively influenced by the presence of the world healthcare regulatory bodies such as the U.S. Food and Drug Administration (FDA), and CDC in the region. Moreover, the increasing government investments in advancing healthcare facilities in the region drive the market.
Asia Pacific is expected to dominate the market during the projection period, owing to the increasing awareness among the population regarding cardiovascular diseases. The governments of developing countries are focusing on taking progressive steps towards advancing healthcare facilities on the country level. Furthermore, increasing facilities for cardiovascular disease treatment and the rising medical tourism for cardiac surgeries is expected to drive the market in coming years.
The aortic stents market has been segmented on the basis of
Key players competing in the global aortic stents market are Cook Group companies; Medtronic; W. L. Gore & Associates, Inc.; Lombard Medical; Artivion, Inc.; Terumo Medical Corporation; BD; and Endologix LLC.
These key players use several business development strategies such as partnerships, mergers, collaboration, acquisitions, product launches, and production expansions to expand their business worldwide. For instance,